Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paulo M Hoff

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Seminars in Oncology|February 8, 2005
Future directions in the use of antiangiogenic agents in patients with colorectal cancerPaulo M Hoff
Clinical Advances in Hematology & Oncology : H&O|August 4, 2007
Novel agents and targets for the therapy of advanced colon cancerPaulo M Hoff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Is there a role for routine p53 testing in colorectal cancer?Paulo M Hoff
Nature Clinical Practice. Oncology|November 3, 2005
Oxaliplatin-related neurotoxicity: is chelation the solution?Paulo M Hoff
Seminars in Oncology|December 6, 2006
Bevacizumab in older patients and patients with poorer performance statusPaulo M Hoff
Clinical Colorectal Cancer|July 6, 2012
Antiangiogenic drugs for colorectal cancer: exploring new possibilitiesRenata Ferrarotto, Paulo M Hoff
Oncology (Williston Park, N.Y.)|June 25, 2004
Progress in the development of novel treatments for colorectal cancerPaulo M Hoff, Richard Pazdur
Oncology (Williston Park, N.Y.)|March 1, 2006
Cytotoxic chemotherapy for advanced colorectal cancer. Recent advances in managementScott Kopetz, Paulo M Hoff
Expert Opinion on Pharmacotherapy|August 10, 2005
Angiogenesis inhibitors in the treatment of cancerJay Rhee, Paulo M Hoff
Oncology|November 20, 2010
Bevacizumab plus irinotecan-based regimens in the treatment of metastatic colorectal cancerVolker Heinemann, Paulo M Hoff
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Seminars in Oncology|February 8, 2005
Future directions in the use of antiangiogenic agents in patients with colorectal cancerPaulo M Hoff
Clinical Advances in Hematology & Oncology : H&O|August 4, 2007
Novel agents and targets for the therapy of advanced colon cancerPaulo M Hoff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Is there a role for routine p53 testing in colorectal cancer?Paulo M Hoff
Nature Clinical Practice. Oncology|November 3, 2005
Oxaliplatin-related neurotoxicity: is chelation the solution?Paulo M Hoff
Seminars in Oncology|December 6, 2006
Bevacizumab in older patients and patients with poorer performance statusPaulo M Hoff
Clinical Colorectal Cancer|July 6, 2012
Antiangiogenic drugs for colorectal cancer: exploring new possibilitiesRenata Ferrarotto, Paulo M Hoff
Oncology (Williston Park, N.Y.)|June 25, 2004
Progress in the development of novel treatments for colorectal cancerPaulo M Hoff, Richard Pazdur
Oncology (Williston Park, N.Y.)|March 1, 2006
Cytotoxic chemotherapy for advanced colorectal cancer. Recent advances in managementScott Kopetz, Paulo M Hoff
Expert Opinion on Pharmacotherapy|August 10, 2005
Angiogenesis inhibitors in the treatment of cancerJay Rhee, Paulo M Hoff
Oncology|November 20, 2010
Bevacizumab plus irinotecan-based regimens in the treatment of metastatic colorectal cancerVolker Heinemann, Paulo M Hoff
Pageof 17